Ocular Therapeutix (OCUL) Revenue (2014 - 2026)
Ocular Therapeutix's Revenue was $13.48 million in Q2 2026, up 0.1% from $13.46 million a year earlier and up 24.9% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Revenue (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocular Therapeutix's Revenue was $52.05 million through Jun 30, 2026, down 8.1% year-over-year; for FY2025, it came in at $51.95 million, down 18.5% from FY2024.
- Revenue shows a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
- In earlier years, Revenue was $63.72 million in FY2024 (+9.0%), $58.44 million in FY2023 (+13.5%), $51.49 million in FY2022 (+18.3%) and $43.52 million in FY2021 (+150.1%).
- Quarterly Revenue has moved between $10.7 million (Q1 2025) and $17.08 million (Q4 2024) over five years.
- Compared with a year earlier, Revenue was higher in four of the last eight quarters, with an average decline of 6.9%.
- The best year-over-year quarter for Revenue over five years was Q3 2021 (growth of 106.8%); the worst was Q1 2025 (a decline of 27.6%).
- Per Business Quant data, OCUL's Revenue in the three quarters before Q2 2026 was $10.79 million (Q1 2026), $13.25 million (Q4 2025) and $14.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Ocular Therapeutix | 1.49 Bn | -860.24 Mn | 11.46 Mn | 13.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.48 Mn |
| Mar 31, 2026 | 10.79 Mn |
| Dec 31, 2025 | 13.25 Mn |
| Sep 30, 2025 | 14.54 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 10.70 Mn |
| Dec 31, 2024 | 17.08 Mn |
| Sep 30, 2024 | 15.43 Mn |
| Jun 30, 2024 | 16.44 Mn |
| Mar 31, 2024 | 14.77 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 15.08 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 13.37 Mn |
| Dec 31, 2022 | 14.08 Mn |
| Sep 30, 2022 | 11.97 Mn |
| Jun 30, 2022 | 12.27 Mn |
| Mar 31, 2022 | 13.19 Mn |
| Dec 31, 2021 | 12.31 Mn |
| Sep 30, 2021 | 12.15 Mn |
API Access
Ocular Therapeutix Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();